Tried and trusted Beconase® has been treating allergic rhinitis, commonly known as hayfever, for almost 30 years. It is often recommended as a ‘first choice’ option for sufferers of both intermittent and persistent forms of the condition who are looking to prevent theirsymptoms as well as treat them(i)(ii).

Beconase® has an anti-inflammatory action and works to both prevent and treat the onset of allergic symptoms such as inflammation and swelling in the nose(iii). This is why Beconase is often preferred by the moderate to severe hayfever sufferer. Broken sleep, restricted daily activities and impaired work or sport can now be managed and controlled effectively. With just 2 sprays, twice a day, life can go on as usual and there’s no reason why everyday can’t be a beautiful day!

Ingredients
Beclomethasone dipropionate 50mcg per spray, Phenylethyl alcohol 2.5uL/g, Benzalkonium chloride 0.2mg/g.

Directions
For adults & children 12 years and over, the usual dose is two sprays into each nostril twice daily.

References: (i) APF22, (ii) Walls et al 2005, (iii) Small and Kim 2011

ALWAYS READ THE LABEL. USE ONLY AS DIRECTED. IF SYMPTOMS PERSIST SEE YOUR HEALTHCARE PROFESSIONAL.
Beconase® is a registered trademark of GlaxoSmithKline Australia Pty Ltd. Marketed & Distributed by Aspen Pharmacare Australia Pty Ltd.